Skip to main content
Submitted by Dr S. Patel on 6 May 2017

This time in our health by numbers/tests series, Dr Shital Raval takes a look at our platelet count that can be determined by a routine blood test. If the platelet count is high or low from the normal range, it can provide insight into various abnormalities and blood disorders including infections and cancer.

A platelet count test is conducted to check the number of platelets in the blood. This test is usually a part of the CBC or complete blood count. Here is a look at what platelet count means.

What are platelets?

Platelets are plate-shaped cells found circulating in the blood. They are the cells responsible for blood clotting and being the first responders to any broken blood vessel. A platelet count can provide insight into various conditions that may affect efficient clotting such as bleeding disorders, infections, blood cancers etc.

When is it ordered?

If a person presents with any of the following symptoms or signs, a CBC with platelet count is ordered.

  • Frequent nosebleeds
  • Prolonged bleeding from wounds, gums or GI tract
  • Unexplained or easy bruising
  • Heavy menstrual flow
  • Petechiae (tiny red spots on the skin)
  • Purpura (purple spots due to bleeding under the skin)

Normal range:

150,000 to 450,000 per microliter of blood

What do the test results mean?

A low platelet count is called thrombocytopenia which means the platelet count is less than 150,000. This may be due to:

  • Decreased platelet production
  • Destruction of platelets in the blood
  • Destruction of platelets in the spleen or liver
RESULTS POSSIBLE CAUSES

Low platelet count (< 150,000)

Idiopathic thrombocytopenia (ITP) or Immune thrombocytopenic purpura, are Autoimmune disorders where the immune system makes antibodies against platelets.
Chemotherapy or radiation therapy
Drug induced decrease may be due to aspirin and ibuprofen, some antibiotics (including those containing sulfa), colchicine and indomethacin, H2-blocking agents, hydralazine, isoniazid, quinidine, thiazide diuretics, and tolbutamide.
Heparin-induced thrombocytopenia (HIT) when a person who is on or received heparin therapy develops an antibody. 
Viral infections such as mononucleosishepatitisHIV or measles. Mosquito-borne diseases such as dengue, chhikungunya or malaria.
Leukaemialymphoma, or any cancer that may have spread (metastasized) to the bone marrow. Increased cancer cells in the bone marrow affect platelet production. 
Aplastic anemia—a blood disorder where the bone marrow does not make enough new blood cells.
GI bleeding due to chronic stomach ulcers, polyps etc.
Cirrhosis- scarring of the liver
Sepsis-life-threatening bacterial infection in the body.
Platelet destruction due to conditions like and hemolytic uremic syndrome (HUS), disseminated intravascular coagulation (DIC), or thrombocytopenic purpura (TTP).
Toxic chemical (arsenic, benzene, pesticides etc) exposure 
   

*If the platelet count drops below 20,000 per microliter the patient is at severe risk of spontaneous bleeding. At this point platelet transfusion may be required.

A high platelet count is called thrombocytosis or thrombocythemia which means the platelet count is above 450,000. This may be due to:

  1. Primary Thrombocythemia where too many or abnormal platelets are produced by the bone marrow. In the absence of any blood disorders, it is called Essential Thromocythemia. It can even be due to a genetic JAK2 mutation.
  2. Secondary Thrombocythemia is where an external factor causes high platelet production.
RESULTS POSSIBLE CAUSES

Low platelet count (< 150,000)

Primary Thrombocythemia

Myeloproliferative disorder such as Polycthemia vera, Chronic Myeloid leukemia etc.

Von Willebrand disease
Secondary Thrombocythemia

Iron deficiency or Hemolytic anemia

Cancer of the lung, GI tract, ovary, breast or blood.

Absence of a spleen.

Inflammatory diseases such as IBS, or Rheumatoid arthritis.

Infectious diseases like Tuberculosis

Certain medications such as Oral contraceptives.
Transient Thrombocythemia ( lasting for only a short period)

Recovery after major blood loss

Alcohol binge

Vitamin B12 or folate deficiency

Strenuous exercise/activity

Recent acute infection
     

Mean Platelet Volume or MPV:

This is the measurement of the average size of platelets circulating in the blood. This result helps evaluate production or destruction of platelets if any in the blood. Young platelets produced by the bone marrow are larger in size then the older platelets.

Normal range of MVP is 7.5-11.5 femtoliter

 

RESULTS WHAT IT MEANS POSSIBLE CAUSES
High MPV (larger size platelets) Body is making new platelets! This increases clotting tendencies and risk of stroke or thrombosis. Recent infection, surgery or blood loss.
Low MPV (smaller size platelets) Body is not making new platelets! This increases risk of bleeding. Bone marrow disorders like aplastic anemia, Chronic kidney failure, sepsis, enlarged spleen or toxic drugs.
       

**A result of normal platelet count with High MPV is a sign of Idiopathic thrombocytopenic purpura, hyperthyroidism or chronic myeloid leukaemia! This indicates that the bone marrow is producing platelets but they are getting destroyed.

Changed
Sun, 09/22/2019 - 16:08

Stories

  • My cancer doesn't define who I am
    "I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
  • Joan Lunden talks about her Breast Cancer
    How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
  • Did you know that womb cancer is the fourth most common cancer in women ?
    My cancer could have been caught earlier if I had been alerted about spotting between periods, heavy periods and watery blood between periods as the main symptoms of womb cancer,” she says. But when she asked NHS Choices whether there should be mention of womb cancer on the menopause pages, she received the following reply: “The problem with adding a warning about womb cancer to the menopause pages is that it may cause unnecessary panic.” And this, says Widschwendter, is the nub of the problem…
  • U.S. FDA Approves New Indication for the Use of Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
    The FDA initially approved XTANDI, an oral, once-daily androgen receptor inhibitor, in August 2012 for use in patients with metastatic CRPC who previously received docetaxel (chemotherapy). The new indication approves XTANDI for use in men with metastatic CRPC who have not received chemotherapy. Metastatic CRPC is defined as a cancer that has spread beyond the prostate gland and has progressed despite treatment to lower testosterone (i.e., with a gonadotropin-releasing hormone (GnRH) therapy or…
  • Heal Your Cancer
    Don’t fight cancer, heal it by attending to body, mind and spirit, says surgical oncologist Dr Vishal Rao. A child developing from an embryo in a mother’s womb is, in reality, a set of rapidly multiplying cells. But they are controlled and regulated. So, we choose to ‘love’ those cells. But when another set of cells multiply rapidly within our body, albeit haphazardly, we call it ‘Cancerous’! These cells are not foreign cells that have made an appearance from outside,…
  • “I was open to anything, just trying to find things to help me stay alive,” said Geoffrey Boycott
    Geoffrey Boycott describes how counting off his radiotherapy sessions like runs in cricket and Feng Shui helped him survive cancer http://www.telegraph.co.uk/sport/cricket/11080199/Geoffrey-Boycott-reve…
  • FDA approves first non-invasive home based DNA screening test for colorectal cancer
    The U.S. Food and Drug Administration approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer. Cologuard offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home. Colorectal cancer was the third most…
  • Mayo Clinic partners with IBM to match Cancer Patients with Clinical Trials
    Mayo Clinic unveiled today a partnership with IBM to harness the power of its Watson supercomputer to match patients with the right clinical trials. Starting early next year, Watson will initially enroll patients with breast, colorectal and lung cancers based on eligibility. There are 170,000 ongoing clinical trials around the world, however, according to the Center for Information and Study on Clinical Research Participation, only 6% are completed on time. Enrolling patients in the…
  • FDA approves first use of novel immune system drug for cancer
    This new class of drugs unleashes the body's immune system to fight tumors. This seems to solve a century-old mystery of how cancerous cells manage to evade the body's immune system. The drug which Merck will sell under the name of Keytruda was approved by patients with advanced melanoma who have exhausted other therapies.  http://www.nytimes.com/2014/09/05/business/merck-wins-approval-of-novel-immune-system-drug-for-cancer.html?emc=eta1
  • Do more for depressed cancer patients
    Clinical depression was much more prevalent among cancer patients than in the general population, where around 2% of people suffer from the mental illness at any point in time. Among cancer patients, clinical depression ranged from 13% in people with lung cancer to 6% in people with genitourinary cancer. The study's lead author Michael Sharpe, from Oxford University, said: "Major depression is really quite common in people with cancer and the perhaps surprising finding is that most of it goes…